{
    "root": "2ef8a999-c2db-ef91-8a61-94663c09d584",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "JAIMIESS",
    "value": "20241125",
    "ingredients": [],
    "indications": "jaimiess indicated females reproductive potential prevent pregnancy .",
    "contraindications": "take one tablet daily mouth time every day 91 days order directed blister pack . ( 2 )",
    "warningsAndPrecautions": "supplied jaimiess ( levonorgestrel ethinyl estradiol tablets , usp ethinyl estradiol tablets , usp ) available extended-cycle tablet blister pack , pouch contains 91 tablets . extended-cycle tablet blister pack contains 13-week supply tablets : 84 white off-white tablets , containing 0.15 mg levonorgestrel 0.03 mg ethinyl estradiol , 7 light peach tablets containing 0.01 mg ethinyl estradiol . white off-white tablets round , biconvex tablets debossed 202 one side plain side . light peach tablets round , biconvex tablets debossed 222 one side plain side . ndc 70700-206-93 carton containing 2 extended-cycle tablet blister packs storage handling store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0 f ) [ usp controlled room temperature ] .",
    "adverseReactions": "jaimiess contraindicated females known develop following conditions : high risk arterial venous thrombotic diseases . examples include females known : -smoke , age 35 [ boxed warning ( 5.1 ) ] . -have current history deep vein thrombosis pulmonary embolism [ ( 5.1 ) ] . -have cerebrovascular disease [ ( 5.1 ) ] . -have coronary artery disease [ ( 5.1 ) ] . -have thrombogenic valvular thrombogenic rhythm diseases heart ( example , subacute bacterial endocarditis valvular disease , atrial fibrillation ) [ ( 5.1 ) ] . -have inherited acquired hypercoagulopathies [ ( 5.1 ) ] . -have uncontrolled hypertension hypertension vascular disease [ ( 5.3 ) ] . -have diabetes mellitus age 35 , diabetes mellitus hypertension vascular disease end-organ damage , diabetes mellitus > 20 years duration [ ( 5.7 ) ] . -have headaches focal neurological symptoms , migraine headaches aura , age 35 migraine headaches [ ( 5.8 ) ] . current diagnosis , history , breast cancer , may hormone sensitive [ ( 5.11 ) ] . liver tumors , acute viral hepatitis , severe ( decompensated ) cirrhosis [ ( 5.2 ) ( 8.6 ) ] . undiagnosed abnormal uterine bleeding [ ( 5.9 ) ] . hepatitis c combinations containing ombitasvir/paritaprevir/ritonavir , without dasabuvir , due potential alt elevations [ ( 5.4 ) ] .",
    "indications_original": "Jaimiess is indicated for use by females of reproductive potential to prevent pregnancy.",
    "contraindications_original": "Take one tablet daily by mouth at the same time every day for 91 days in the order directed on the blister pack. ( 2 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  Jaimiess (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) is available in an Extended-Cycle Tablet Blister Pack, each pouch contains 91 tablets. Each Extended-Cycle Tablet Blister Pack contains a 13-week supply of tablets: 84 white to off-white tablets, each containing 0.15 mg of levonorgestrel and 0.03 mg ethinyl estradiol, and 7 light peach tablets each containing 0.01 mg of ethinyl estradiol. The white to off-white tablets are round, biconvex tablets debossed with 202 on one side and plain on the other side. The light peach tablets are round, biconvex tablets debossed with 222 on one side and plain on the other side.\n                  NDC 70700-206-93 Carton containing 2 Extended-Cycle Tablet Blister Packs\n                  \n                     Storage and Handling\n                  \n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0 F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Jaimiess is contraindicated in females who are known to have or develop the following conditions:\n                  \n                     \n                        A high risk of arterial or venous thrombotic diseases. Examples include females who are known to:\n                        \n                           \n                              -Smoke, if over age 35 [see Boxed Warning and Warnings and Precautions (5.1)].\n                           \n                              -Have current or history of deep vein thrombosis or pulmonary embolism [see Warnings and Precautions (5.1)].\n                           \n                              \n                                 -Have cerebrovascular disease [see Warnings and Precautions (5.1)].\n                           \n                           \n                              -Have coronary artery disease [see Warnings and Precautions (5.1)].\n                           \n                              -Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see Warnings and Precautions (5.1)].\n                           \n                              -Have inherited or acquired hypercoagulopathies [see Warnings and Precautions (5.1)].\n                           \n                              -Have uncontrolled hypertension or hypertension with vascular disease [see Warnings and Precautions (5.3)].\n                           \n                              \n                                 -Have diabetes mellitus and are over age 35, diabetes mellitus with hypertension or with vascular disease or other end-organ damage, or diabetes mellitus of > 20 years duration [see Warnings and Precautions (5.7)].\n                           \n                           \n                              \n                                 -Have headaches with focal neurological symptoms, migraine headaches with aura, or over age 35 with any migraine headaches [see Warnings and Precautions (5.8)].\n                           \n                        \n                     \n                     \n                        Current diagnosis of, or history of, breast cancer, which may be hormone sensitive [see Warnings and Precautions (5.11)].\n                        \n                     \n                     \n                        Liver tumors, acute viral hepatitis, or severe (decompensated) cirrhosis [see Warnings and Precautions (5.2) and Use in Specific Populations (8.6)]. \n                        \n                     \n                     \n                        Undiagnosed abnormal uterine bleeding [see Warnings and Precautions (5.9)].\n                        \n                     \n                     \n                        Use of Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations [see Warnings and Precautions (5.4)]."
}